An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Traction Online
Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors market the drug there before directing customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in users administering substances of uncertain source.
Some experts stated the popularity for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or imprisonment.
Platform Response and Material Elimination
Based on TikTok, the service has taken down problematic material and banned associated keywords and search suggestions. The organization said it was committed to keeping the platform secure and investing in strengthening compliance measures.
Digital Marketplace Operations
Investigations also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, filled with images of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence.
Within moments of entering one group, a vendor shared contact information, where the majority of purchases take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.
Item Information and Pricing
Inside these groups, posts display black plastic parcels with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting materials they cannot confirm. Even if the research behind this drug is sound, these online versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has already encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may subject patients to possibly serious medical dangers”.
